Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_assertion type Assertion NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_head.
- NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_assertion description "[The development of myelodysplastic syndrome/acute myeloblastic leukaemia (MDS/AML) has been reported in patients with aplastic anaemia (AA) after administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_provenance.
- NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_assertion evidence source_evidence_literature NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_provenance.
- NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_assertion SIO_000772 11122117 NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_provenance.
- NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_assertion wasDerivedFrom befree-2016 NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_provenance.
- NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_assertion wasGeneratedBy ECO_0000203 NP303453.RADrYFOZMtbs6fYYM6m6DVSURDEH3kk8-NvlgQvqoNuIE130_provenance.